Pennsylvania Federal Judge: Expert Challenge In Antitrust Case Fails
PHILADELPHIA — Efforts by a direct purchaser class of the brand-name drug Provigil, covered by U.S. reissue patent No. 37,516, to preclude experts for five pharmaceutical companies from opining, generally, that...To view the full article, register now.
Already a subscriber? Click here to view full article